ArticleJournal of the Saudi Heart Association2026
Optimizing Heart Failure-Specific Disease Management Programs and Patient Care in Saudi Arabia: A Saudi Heart Association Position Statement.
Article in Journal of the Saudi Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart failure (HF) represents a major and growing health burden in Saudi Arabia, with high morbidity, frequent hospitalizations, and substantial system-level costs. Despite advances in guideline-directed medical therapy, gaps in diagnosis, care coordination, and longitudinal management persist. Structured, multidisciplinary heart failure-specific disease management programs (HF-DMPs) have been shown to improve outcomes and healthcare efficiency, yet their implementation remains inconsistent across the Kingdom. Methods: The Saudi Heart Association (SHA) convened a multidisciplinary expert panel to develop a national position statement on HF-DMPs. Recommendations were formulated through structured consensus, informed by a comprehensive review of international guidelines, clinical trials, real-world evidence, and Saudi-specific data. Results and conclusions: The SHA recommends a patient-centered, multidisciplinary HF-DMP framework aligned with disease stage and institutional capacity. Core components include structured referral and return-of-care pathways, integration of primary care as longitudinal care owners, optimized use of multidisciplinary teams, and scalable models incorporating virtual care and home-based services. Special populations, including cardio-oncology, pregnancy-associated HF, and cardiomyopathies, are addressed through adaptive multidisciplinary pathways. Performance indicators and quality metrics are proposed to support benchmarking and continuous improvement. Crucially, this framework is designed to synergize with the Kingdom's Model of Care, ensuring that these clinical recommendations also offer a practical tool for the new healthcare system. Implementation of structured, capacity-based HF-DMPs is recommended as a pragmatic and scalable approach to enhance care coordination, optimize resource utilization, and reduce preventable HF morbidity and hospitalization at a national level.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.